Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Homerun Slides: Clinical presentation library Previous | All Articles This Week | Next
This article originally posted 12 September, 2011 and appeared in  MedicationType 2 DiabetesMedication SlidesDiabetes Clinical Mastery Series Issue 50GLP-1 Receptor Agonist Therapy

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 3 of 5

DCMS50_HS_Image

We continue this week with our Homerun Slides series on Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents with slides on Incretins and DPP 4 Inhibitors....

Link to download (.ppt format): Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 3 of 5

Other sets in this series:

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 1 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 2 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 4 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 5 of 5

Check out all of Diabetes In Control's slide collections at our new Clinical Presentations Library.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 12 September, 2011 and appeared in  MedicationType 2 DiabetesMedication SlidesDiabetes Clinical Mastery Series Issue 50GLP-1 Receptor Agonist Therapy

Past five issues: Diabetes Clinical Mastery Series Issue 137 | Issue 677 | SGLT2 Special Edition Issue 2 | Diabetes Clinical Mastery Series Issue 136 | Issue 676 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
What test do you use to screen for prediabetes?

Navigate Diabetes In Control
Search Articles On Diabetes In Control